Trials
BOSTON, MA: WCC President Rick Walovitch to Present on Central Review for Trials With Subjective Endpoints at CBI Bio/Pharmaceutical Imaging Forum on December 11th ...
LOS ALTOS, CA: LOS ALTOS, CA -- (Marketwire) -- 12/05/12 -- Pherin Pharmaceuticals announced today that a Phase II clinical trial showed that its proprietary compound PH94B demonstrated significant benefits in the ...
CARLSBAD, CA: CARLSBAD, CA -- (Marketwire) -- 12/04/12 -- International Stem Cell Corporation (OTCQB: ISCO) () ("ISCO" or "the Company"), a California-based biotechnology company focused on the ...
BOSTON, MA: Leverages Established Clinical Infrastructure to Facilitate Real-Time Global Site Support ...
ATLANTA, GA: Special Track for Principal Investigators Offers CME Credits ...
NEW YORK, NY: Study Demonstrated Desirable Pharmacokinetic Profile With Rapid Absorption Well-Suited for Bedtime Use ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 10/23/12 -- Biota Holdings Limited (ASX: BTA) (Biota) announces that the shareholders of Nabi Biopharmaceuticals Inc. (Nabi) have approved proposals related to ...
TUSTIN, CA: Company Replaces Prior Loan Facility With Over $14 Million in Financing Proceeds Received Since September 27th; Growing Contract Manufacturing Business Remains on Track for Record Revenue Year; Multip ...
BEVERLY, MA: BEVERLY, MA -- (Marketwire) -- 10/08/12 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to tr ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 09/26/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that clinical data on its investigational hypoxia-targeted drug, TH-302, will be ...
TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 09/07/12 --Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that interim results were presented from its 121 patient randomized, double-blind, placebo-cont ...
TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 08/29/12 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment ...
MANCHESTER, NH: Initiated launch of SUGARDOWN(R) in the U.S. at the Endocrinology Annual Meeting; SUGARDOWN(R) Sales Increased 845% in the First Half of 2012; Completed Patient Enrollment for Phase II PAZ320 Clinical ...
CAMBRIDGE, MA: Webcast Accessible via Sarepta Therapeutics Website ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 07/23/12 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of RNA-based therapeutics, today announced it will hold a conference call at 8:00 a.m. EDT (5:00 a. ...
SOUTH SAN FRANCISCO, CA and SAN DIEGO, CA: SOUTH SAN FRANCISCO, CA and SAN DIEGO, CA -- (Marketwire) -- 06/13/12 -- Full Spectrum Genetics, Inc., a privately-held biopharmaceutical company, and BioBlocks, Inc., a privately-held small molecul ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 06/01/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that Executive Chairman, Geoffrey Kempler is scheduled to present a corporate update ...
LONGVIEW, WA: LONGVIEW, WA -- (Marketwire) -- 05/24/12 -- Cromos™ Pharma, a full service, regional Contract Research Organization (CRO), announced today that it will participate and exhibit at the Annual Meetin ...
